Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin AF for Bacterial Conjunctivitis
NCT00332293Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- May 2006
- Primary completion
- Dec 2006
- Countries
- 1
01
Overview
A Phase 3 trial of Moxisurge in bacterial conjunctivitis (BC), sponsored by Alcon Inc.. Started May 2006; status: completed.
02
Drugs
Moxisurge
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00332293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332293.